prmarks logo

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit

News provide by
702Padmin
Sep 23, 2024, 11:30 AM PDT

Share this article

NEW YORK, Sept. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”) of the important October 28,…